GAM Holding’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-11,200
Closed -$441K – 209
2023
Q2
$441K Buy
+11,200
New +$395K 0.03% 180
2017
Q1
– Sell
-60,300
Closed -$291K – 1102
2016
Q4
$291K Buy
60,300
+28,800
+91% +$855K 0.01% 885
2016
Q3
$1.45M Sell
31,500
-31,500
-50% -$1.78M 0.03% 546
2016
Q2
$3.22M Buy
63,000
+31,500
+100% +$1.57M 0.05% 396
2016
Q1
$1.33M Buy
+31,500
New +$1.6M 0.02% 574

GAM Holding's ISEE Position: Q3 2023 in Review

GAM Holding sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 11,200 shares — an estimated $441K sold.

GAM Holding first reported a position in ISEE in Q1 2016 and held it in 5 quarters. The position peaked at $3.22M in Q2 2016. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • GAM Holding reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • GAM Holding sold 11,200 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $441K.
  • GAM Holding first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 5 quarters.
  • GAM Holding's IVERIC bio, Inc. Common Stock position peaked at $3.22M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on GAM Holding's 13F filing for Q3 2023, filed 16 Oct 2023.